Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. 詳細を表示
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company”...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.15 | -8.87573964497 | 1.69 | 1.69 | 1.45 | 9926 | 1.64673837 | CS |
4 | -0.23 | -12.9943502825 | 1.77 | 1.8 | 1.45 | 30132 | 1.63819536 | CS |
12 | -0.3 | -16.3043478261 | 1.84 | 1.95 | 0.8001 | 30515 | 1.40387932 | CS |
26 | -0.66 | -30 | 2.2 | 3.08 | 0.8001 | 17135 | 1.58331614 | CS |
52 | -0.91 | -37.1428571429 | 2.45 | 3.3 | 0.8001 | 11718 | 1.85979529 | CS |
156 | -5.07 | -76.7019667171 | 6.61 | 7.885 | 0.8001 | 10311 | 2.78713925 | CS |
260 | -5.84 | -79.1327913279 | 7.38 | 9.33 | 0.8001 | 11156 | 3.90964672 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約